Asuragen has secured approval from the US Food and Drug Administration (FDA) for its genetic test to diagnose Fragile X Syndrome (FXS). Individuals with a full mutation have
The post Asuragen gets FDA nod for genetic test to diagnose Fragile X Syndrome appeared first on NS Medical Devices.
Original Article: Asuragen gets FDA nod for genetic test to diagnose Fragile X Syndrome